Autoinjector Market 2022-2027 | Size, Global Industry Growth, Trends and Forecast

The latest research study “Autoinjector Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global autoinjector market size reached a value of US$ 1.65 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.39 Billion by 2027, exhibiting a CAGR of 16.70% during 2022-2027.

Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/autoinjector-market/requestsample

Autoinjectors are self-injecting devices that assist in intramuscular or subcutaneous drug delivery. They offer numerous benefits, including dosage accuracy, enhanced patient compliance, lower needlestick injuries caused by a hidden needle, reduced patient needle phobia, and improved convenience and efficiency of healthcare professionals. They are commonly used during emergencies, such as psoriasis, diabetes, multiple sclerosis, rheumatoid arthritis, anaphylaxis, migraine, and status epilepticus. As a result, autoinjectors find extensive applications in clinics, hospitals, and home care centers.

Autoinjector Market Trends and Drivers:

The global autoinjector market is primarily driven by the rising prevalence of chronic medical conditions, including Alzheimer’s disease, arthritis, cancer, chronic obstructive pulmonary disease (COPD), and asthma. Additionally, the increasing need for self-administrating medicines is positively influencing market growth. Moreover, several favorable initiatives have been taken by governments of numerous countries to promote the use of autoinjectors in schools.

In line with this, the increasing awareness about the benefits of autoinjectors among individuals has catalyzed market growth. Besides this, the surging adoption of targeted therapies to alter proteins in cancer cells and prevent the development of new blood vessels in tumors is propelling market growth. Furthermore, the rising investments by key players in research and development (R&D) activities to develop simple, affordable, and technologically advanced autoinjectors to treat multiple sclerosis and rheumatoid arthritis is contributing to the market growth.

Other factors, including increasing regulatory approvals, rapid expansion in the healthcare industry, upcoming patent expiry of biologics, and easy availability of generic versions of autoinjectors, are also anticipated to drive the market further.

Global Autoinjector Market 2022-2027 Analysis and Segmentation: 

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Autoinjector Companies:

Amgen Inc., Antares Pharma Inc., Becton Dickinson and Company, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Haselmeier GmbH (Sulzer Ltd.), Johnson & Johnson, Mylan N.V. (Viatris Inc.), Novartis AG, SHL Medical AG, Teva Pharmaceutical Industries Ltd. and Ypsomed Holding AG.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/autoinjector-market

The report has segmented the market on the basis of region, type, application and end user.

Breakup by Type:

  • Disposable Autoinjectors
  • Reusable Autoinjectors

Breakup by Application:

  • Rheumatoid Arthritis
  • Anaphylaxis
  • Multiple Sclerosis
  • Others

Breakup by End User:

  • Home Care Settings
  • Hospitals and Clinics

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

 Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Reply

Your email address will not be published. Required fields are marked *